Error: Could not add to watchlist. X
+ Watchlist

Progenics Pharmaceuticals Inc

PGNX:US
NASDAQ GS
9.15
USD
0.28
3.16%
As of 8:10 PM EST 12/9/2016
Open
8.96
Day Range
8.83 - 9.19
Volume
1,180,087
Previous Close
8.87
52Wk Range
3.61 - 9.23
1 Yr Return
114.98%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
8.96
Day Range
8.83 - 9.19
Volume
1,180,087
Previous Close
8.87
52Wk Range
3.61 - 9.23
1 Yr Return
114.98%
YTD Return
49.27%
Current P/E Ratio (TTM)
51.89
Earnings per Share (USD) (TTM)
0.17
Market Cap (m USD)
623.458
Shares Outstanding (m)
70.051
Price/Sales (TTM)
8.92
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.63%
% Price Change
-0.85%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.
Address
1 World Trade Center
47th Floor, Suite J
New York, NY 10007
United States
Phone
1-646-975-2500
Show More